Oral Chinese herbal medicine combined with pharmacotherapy for stable COPD: A systematic review of effect on BODE index and six minute walk test

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Chen, Xiankun ^a,b   May, Brian ^c   Di, Yuan Ming ^c   Zhang, Anthony Lin ^c   Lu, Chuanjian ^a,b   Xue, Charlie Changli ^a,b,c   Lin, Lin ^b  

^a Guangdong Provincial Academy of Chinese Medical Sciences   (China)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^c RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMBROXOL; AMINOPHYLLINE; ANTIBIOTIC AGENT; BAI LING; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BROMHEXINE; CHLORPHENIRAMINE; FLUTICASONE; HERBACEOUS AGENT; IPRATROPIUM BROMIDE; JIN SHUI BAO; LONG ACTING DRUG; OXYGEN; PLACEBO; RESPIRATORY TRACT AGENT; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; UNCLASSIFIED DRUG; YU PING FENG;

6 MINUTE WALK DISTANCE; 6 MINUTE WALK TEST; ABDOMINAL DISTENSION; ADULT; AGED; ANALYTIC METHOD; ASTRAGALUS MEMBRANACEUS; BODE INDEX; CHINESE MEDICINE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSTIPATION; CONTROLLED STUDY; DISEASE CONTROL; DRUG EFFECT; DRUG THERAPY; FEMALE; GINSENG; HEART PALPITATION; HERBAL MEDICINE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OBSERVATIONAL STUDY; OPHIOCORDYCEPS; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; ROUTINE PHARMACOTHERAPY; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; DRUG INTERACTION; EXERCISE TEST; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TIME; WALKING;

ADMINISTRATION, ORAL; DRUG INTERACTIONS; DRUGS, CHINESE HERBAL; EXERCISE TEST; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TIME FACTORS; WALKING;

EID: 84898749971     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091830     Document Type: Review

References (70)

1. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, et al. (2011) Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 155: 179-191.
2. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349: 1498-1504. (Pubitemid 27216360)
3. George J, Ioannides-Demos LL, Santamaria NM, Kong DC, Stewart K (2004) Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease. Med J Aust 181: 248-251. (Pubitemid 39247882)
4. Hu J, Zhang J, Zhao W, Zhang Y, Zhang L, et al. (2011) Cochrane systematic reviews of Chinese herbal medicines: an overview. PLoS One 6: e28696.
5. Vickers A, Zollman C (1999) ABC of complementary medicine: herbal medicine. BMJ 319: 1050-1053.
6. Shin IS, Lee MY, Lim HS, Ha H, Seo CS, et al. (2012) An extract of Crataegus pinnatifida fruit attenuates airway inflammation by modulation of matrix metalloproteinase-9 in ovalbumin induced asthma. PLoS One 7: e45734.
7. Kim HG, Shrestha B, Lim SY, Yoon DH, Chang WC, et al. (2006) Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage cells. Eur J Pharmacol 545: 192-199.
8. Rao YK, Fang SH, Tzeng YM (2007) Evaluation of the anti-inflammatory and anti-proliferation tumoral cells activities of Antrodia camphorata, Cordyceps sinensis, and Cinnamomum osmophloeum bark extracts. J Ethnopharmacol 114: 78-85. (Pubitemid 47444512)
9. Shahed AR, Kim SI, Shoskes DA (2001) Down-regulation of apoptotic and inflammatory genes by Cordyceps sinensis extract in rat kidney following ischemia/reperfusion. Transplant Proc 33: 2986-2987. (Pubitemid 32785621)
10. Denzler KL, Waters R, Jacobs BL, Rochon Y, Langland JO (2010) Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals. PLoS One 5: e12561.
11. Koh JH, Yu KW, Suh HJ, Choi YM, Ahn TS (2002) Activation of macrophages and the intestinal immune system by an orally administered decoction from cultured mycelia of Cordyceps sinensis. Biosci Biotechnol Biochem 66: 407-411.
12. Kuo YC, Tsai WJ, Shiao MS, Chen CF, Lin CY (1996) Cordyceps sinensis as an immunomodulatory agent. Am J Chin Med 24: 111-125.
13. Kuo YC, Tsai WJ, Wang JY, Chang SC, Lin CY, et al. (2001) Regulation of bronchoalveolar lavage fluids cell function by the immunomodulatory agents from Cordyceps sinensis. Life Sci 68: 1067-1082.
14. Shao BM, Xu W, Dai H, Tu P, Li Z, et al. (2004) A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun 320: 1103-1111. (Pubitemid 38916657)
15. Chen N, Li H, Zhao LY, Liu JB, Huang Q, et al. (2009) [Therapy for clearing heat and resolving phlegm in treatment of systemic inflammatory response syndrome in acute deterioration stage of chronic obstructive pulmonary disease: a randomized controlled trial]. Zhong Xi Yi Jie He Xue Bao 7: 105-109.
16. Cui P, Wang YN, Gao TS, Qi TC, Mei L, et al. (2012) [Study on mechanism of traditional Chinese medicines reducing phlegm and resolving masses in treatment of goiter]. Zhongguo Zhong Yao Za Zhi 37: 3451-3456.
17. Chan E, Tan M, Xin J, Sudarsanam S, Johnson DE (2010) Interactions between traditional Chinese medicines and Western therapeutics. Curr Opin Drug Discov Devel 13: 50-65.
18. An X, Zhang AL, May BH, Lin L, Xu Y, et al. (2012) Oral Chinese herbal medicine for improvement of quality of life in patients with stable chronic obstructive pulmonary disease: a systematic review. J Altern Complement Med 18: 731-743.
19. Jones PW (2001) Health status measurement in chronic obstructive pulmonary disease. Thorax 56: 880-887.
20. Glaab T, Vogelmeier C, Buhl R (2010) Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res 11: 79.
21. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR (2004) The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 23: 28-33. (Pubitemid 38088492)
22. Brown CD, Wise RA (2007) Field tests of exercise in COPD: the six-minute walk test and the shuttle walk test. COPD 4: 217-223. (Pubitemid 47345891)
23. Wise RA, Brown CD (2005) Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD 2: 125-129. (Pubitemid 40776232)
24. Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, et al. (2010) Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 91: 221-225.
25. Spruit MA, Polkey MI, Celli B, Edwards LD, Watkins ML, et al. (2012) Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. Joural of the American Medical Directors Association 13: 291-297.
26. Cote CG, Casanova C, Marin JM, Lopez MV, Pinto-Plata V, et al. (2008) Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J 31: 571-578.
27. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, et al. (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350: 1005-1012. (Pubitemid 38269277)
28. Ong KC, Earnest A, Lu SJ (2005) A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 128: 3810-3816. (Pubitemid 43062640)
29. Pinto-Plata V, Casanova C, Mullerova H, de Torres JP, Corado H, et al. (2012) Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD. Respir Res 13: 71.
30. Faganello MM, Tanni SE, Sanchez FF, Pelegrino NR, Lucheta PA, et al. (2010) BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease. Am J Med Sci 339: 10-14.
31. Marin JM, Cote CG, Diaz O, Lisboa C, Casanova C, et al. (2011) Prognostic assessment in COPD: health related quality of life and the BODE index. Respir Med 105: 916-921.
32. Imfeld S, Bloch KE, Weder W, Russi EW (2006) The BODE index after lung volume reduction surgery correlates with survival. Chest 129: 873-878.
33. Shang Q, Xu H, Huang L (2012) Tanshinone IIA: A Promising Natural Cardioprotective Agent. Evid Based Complement Alternat Med 2012: 716459.
34. GOLD (2011) Global Strategy for Diagnosis, Management and Prevention of COPD The Global Initiative for Chronic Obstructive Lung Disease (GOLD).
35. Higgins JPT, Green S, eds (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration.
36. Chen GC, Li YX, Zhou ZY, Xue HR, Zhang YB (2012) Combination of Buzhong-Yiqi decoction and routine treatment for stable chronic obstructive pulmonary disease [in Chinese]. Shanghai Journal of Traditional Chinese Medicine 46: 42-44.
37. Chen Q, Hong XC, Cai Y, Ye L (2009) Clinical observation of integrated Chinese and western medicine treatment in patients with stable COPD [in Chinese]. Journal of Fujian University of Traditional Chinese Medicine 19: 12-14.
38. Cui CB, Yuan YD, Liu SH, Han DL, Gao XL, et al. (2004) Intervention effect of Tongfei mixture on nocturnal hypoxia in patients with chronic obstructive pulmonary disease [in Chinese]. Chinese Journal of Integrated Traditional and Western Medicine 24: 885-888.
39. Guo WX, Zhang FY, Yan GL (2008) Clinical observation of the therapeutic effect of Jianfei capsule on chronic obstructive pulmonary disease at stationary phase [in Chinese]. Hebei Journal of Traditional Chinese Medicine 30: 121-125.
40. Hu QG, Liu LL (2012) Clinical observation of Jinshuibao capsule combined with Bufeihuoxue capsule in treating patients with stable COPD [in Chinese]. Journal of Guiyang Collage of Traditional Chinese Medicine 34: 135-137.
41. Huang DH, Wu L, He DP, Lin L (2005) Clinical observation of tranquilization period of COPD treated by integration of traditional Chinese medicine and western medicine [in Chinese]. Journal of the Fourth Military Medical University 26: 1611-1613.
42. Jian XY, Huang SQ, Lai X, Chen WY, Jiang RB (2012) Influence of Pingchuan capsules on BODE indexes in patients with stable chronic obstructive pulmonary disease [in Chinese]. Journal of Beijing University of Traditional Chinese Medicine (TCM clinical edition) 19: 32-34.
43. Li SY, Li JS, Wang MH, Xie Y, Yu XQ, et al. (2012) Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study. BMC Complement Altern Med 12: 197.
44. Liao YL, An W, Zhang W (2011) Stable COPD patients treated with Yupingfengsan in addition to routine therapy: 30 cases [in Chinese]. Guiding Journal of Traditional Chinese Medicine and Pharmacy 30: 63-66.
45. Liu CS (2009) Clinical observation on the treatment of 30 cases of chronic obstructive pulmonary disease at stable term by benefiting vital energy and promoting blood, resolving phlegm and dredging collaterals [in Chinese]. Guiding Journal of Traditional Chinese Medicine and Pharmacy 11: 10-12.
46. Mao R (2009) Clinical observation of Bailing capsules in treating stable COPD [in Chinese]. Chinese Journal of Integrated Traditional and Western Medicine 29: 362-367.
47. Shan LN, Liu XH, Zhong LH (2011) The effects of integrated Chinese and western medicine on prognostic indexes of patients with stable chronic obstructive pulmonary disease [in Chinese]. Journal of Guangzhou University of Traditional Chinese Medicine 28: 590-592.
48. Xu JZ, Fan DB, Qin XP, Yang L, Bai HH, et al. (2012) Clinical observation of Gujingao in the treatment of 45 participants with stable COPD [in Chinese]. Yunnan Journal of Traditional Chinese Medicine and Materia Medica 33: 31-32.
49. Xu TZ, Yao XL (2012) Effect observation on treating stable stage of COPD with therapy of Winter Disease In Summer [in Chinese]. Chinese archives of Traditional Chinese Medicine 30: 570-572.
50. Yu JY (2011) The effects of Gejiedingchuanjiaonang on BODE index in patients with stable chronic obstructive pulmonary disease [in Chinese]. Journal of Medical Information 4019.
51. Zhang FY, Liu YH, Li SF (2007) Effects of Bailing capsule combined with ipratropium bromide aerosol on the lung funtion and quality of life in patients with stable COPD [in Chinese]. Journal of Emergency in Traditional Chinese Medicine 19: 198-209.
52. Zhang FY, Wang YL, Li SF (2007) The effects of Basic Chinese Herbal Formula combined with conventional therapy for COPD patients and their exercise tolerence [in Chinese]. Shanxi Zhongyi Journal 28: 1594-1596.
53. Zhang RZ, Zheng SJ, Yan GZ (2011) Observation of the effects of Yupingfengsan combined with Jinshuiliujunjian treatment in patients with modrate COPD [in Chinese]. China Practical Medicine 6: 118-119.
54. Zhao YL, Song HR, Fei JX, Liang Y, Zhang BH, et al. (2012) The effects of Chinese Yam-Epimedium mixture on respiratory function and quality of life in patients with chronic obstructive pulmonary disease. Journal of Traditional Chinese Medicine 32: 203-207.
55. Fan BD, Qin XP, Xu JZ, Bai HH, Yu KS, et al. (2012) Clinical observation on the treatment of Bu-Fei-Jian-Pi-Yi-Shen decoction combined with western medicine for 90 patients with stable COPD [in Chinese]. Journal of Sichuan of Traditional Chinese Medicine: 83-85.
56. Liang AW, Tan YP, Liang W, Nong TQ, Su QJ, et al. (2013) The effect of Run-Fei-Jian-Pi-Bu-Shen decoction on improvement of symptoms and 6MWT of patients with stable COPD [in Chinese]. Journal of Emergency in Traditional Chinese Medicine: 1125-1127.
57. Lin YZ (2013) Clinical observation on integrated Chinese and western medicine treating stable COPD [in Chinese]. Chinese Manipulation and Rehabilitation Medicine: 103-105.
58. Peng ZQ (2013) The effect of No. 1-Bu-Fei decoction on patients with stable COPD of Lung Qi Deficiency syndrome and influence of MMP-9 [Master degree thesis in Chinese]: Fujian University of Traditional Chinese Medicine.
59. Zeng JQ, Liao ZC, Wang SM, Lin LS, Chen WY, et al. (2013) Clinical observation of modified Si-Jun-Zi granules in improving exercise tolerance of patients with COPD [in Chinese]. Journal of New Chinese Medicine: 32-34.
60. Yang CM, Lu YW, He YH (2013) Clinical observation of Tong-Qi-Pai-Yong decoction combined with Seretide for stable COPD [in Chinese]. Modern Journal of Integrated Traditional Chinese and Western Medicine: 729-730.
61. Society AT (1999) Pulmonary rehabilitation-1999. Am J Respir Crit Care Med 159: 1666-1682.
62. CSRD (2007) Chinese Society of Respiratory Disease (CSRD): guideline for diagnosis and management of chronic obstructive pulmonary disease (revision 2007). Chin J Inrern Med 46: 254-261.
63. Cote CG, Celli BR (2005) Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 26: 630-636. (Pubitemid 41448660)
64. Mansori F, Nemat Khorasani A, Boskabady MH, Boskabady M (2010) The effect of inhaled salmeterol, alone and in combination with fluticasone propionate, on management of COPD patients. Clin Respir J 4: 241-247.
65. Wu L, Chen YB, Xu YJ, Guo XF, Li XY, et al. (2013) Oral huangqi formulae for stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2013: 705315.
66. Shergis JL, Zhang AL, Zhou W, Xue CC (2013) Panax ginseng in Randomised Controlled Trials: A Systematic Review. Phytother Res 27: 949-965.
67. An X, Zhang AL, Yang AW, Lin L, Wu D, et al. (2011) Oral ginseng formulae for stable chronic obstructive pulmonary disease: a systematic review. Respir Med 105: 165-176.
68. Li CY, Chiang CS, Cheng WC, Wang SC, Cheng HT, et al. (2012) Gene expression profiling of dendritic cells in different physiological stages under Cordyceps sinensis treatment. PLoS One 7: e40824.
69. Kuo YH, Tsai WJ, Loke SH, Wu TS, Chiou WF (2009) Astragalus membranaceus flavonoids (AMF) ameliorate chronic fatigue syndrome induced by food intake restriction plus forced swimming. J Ethnopharmacol 122: 28-34.
70. Kumar R, Negi PS, Singh B, Ilavazhagan G, Bhargava K, et al. (2011) Cordyceps sinensis promotes exercise endurance capacity of rats by activating skeletal muscle metabolic regulators. J Ethnopharmacol 136: 260-266.